Skip to main content
CRON
NASDAQ Life Sciences

Cronos Jumps Premarket as Q3 Revenue Tops Consensus by 20%

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.752
Mkt Cap
$1.293B
52W Low
$2.28
52W High
$3.608
52W Position info
65% above low
Off High info
at 52W high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

CRON sits 65% above its 52-week low of $2.28 on elevated volume (2.0× avg).

Summary

Cronos reported Q3 2026 net revenue of $63.5M, up 75% year over year and well above the $52.8M consensus, driven by cannabis flower sales in Israel and Germany plus a stronger Israeli shekel. Adjusted EBITDA came in at $17.1M versus $9.7M expected, and net income of $17.8M beat the $11.1M consensus even though it fell about 37% year over year. Gross profit rose 76% to $32.3M on higher volumes and average selling prices, while operating expenses climbed about 24% to $23.3M. The beat follows the October 15 close of the €57.5M CanAdelaar acquisition, which added the largest licensed grower in the Netherlands' adult-use market and supports the international flower volume behind this quarter. Shares are trading near a 52-week high, so the bar was already elevated and the company cleared it on both revenue and EBITDA.

At the time of this announcement, CRON was trading at $3.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $2.28 to $3.61. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

CRON - Latest Insights

CRON
Nov 05, 2026, 7:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $3.06 info
Change: -$0.540 (-15%) info
Market Cap: $1.114B info
CRON
Oct 15, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.17
Real-time Price: $3.06 info
Change: -$0.110 (-3%) info
Market Cap: $1.114B info
CRON
Oct 15, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.17
Real-time Price: $3.06 info
Change: -$0.110 (-3%) info
Market Cap: $1.114B info
CRON
Aug 06, 2026, 7:32 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.08
Real-time Price: $3.06 info
Change: -$0.0245 (-0.79%) info
Market Cap: $1.114B info
CRON
Aug 06, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.08
Real-time Price: $3.06 info
Change: -$0.0245 (-0.79%) info
Market Cap: $1.114B info